342 related articles for article (PubMed ID: 23192981)
1. The role of prolactin receptor in GH signaling in breast cancer cells.
Xu J; Sun D; Jiang J; Deng L; Zhang Y; Yu H; Bahl D; Langenheim JF; Chen WY; Fuchs SY; Frank SJ
Mol Endocrinol; 2013 Feb; 27(2):266-79. PubMed ID: 23192981
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone signaling in human T47D breast cancer cells: potential role for a growth hormone receptor-prolactin receptor complex.
Xu J; Zhang Y; Berry PA; Jiang J; Lobie PE; Langenheim JF; Chen WY; Frank SJ
Mol Endocrinol; 2011 Apr; 25(4):597-610. PubMed ID: 21310852
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone (GH) receptor (GHR)-specific inhibition of GH-Induced signaling by soluble IGF-1 receptor (sol IGF-1R).
Zhang Y; Gc S; Patel SB; Liu Y; Paterson AJ; Kappes JC; Jiang J; Frank SJ
Mol Cell Endocrinol; 2019 Jul; 492():110445. PubMed ID: 31100495
[TBL] [Abstract][Full Text] [Related]
4. GHR/PRLR Heteromultimer Is Composed of GHR Homodimers and PRLR Homodimers.
Liu Y; Zhang Y; Jiang J; Lobie PE; Paulmurugan R; Langenheim JF; Chen WY; Zinn KR; Frank SJ
Mol Endocrinol; 2016 May; 30(5):504-17. PubMed ID: 27003442
[TBL] [Abstract][Full Text] [Related]
5. Development of a novel ligand that activates JAK2/STAT5 signaling through a heterodimer of prolactin receptor and growth hormone receptor.
Langenheim JF; Chen WY
J Recept Signal Transduct Res; 2009; 29(2):107-12. PubMed ID: 19519175
[TBL] [Abstract][Full Text] [Related]
6. Subdomain 2, Not the Transmembrane Domain, Determines the Dimerization Partner of Growth Hormone Receptor and Prolactin Receptor.
Liu Y; Jiang J; Lepik B; Zhang Y; Zinn KR; Frank SJ
Endocrinology; 2017 Oct; 158(10):3235-3248. PubMed ID: 28977606
[TBL] [Abstract][Full Text] [Related]
7. Prolactin induces up-regulation of its cognate receptor in breast cancer cells via transcriptional activation of its generic promoter by cross-talk between ERα and STAT5.
Kavarthapu R; Tsai Morris CH; Dufau ML
Oncotarget; 2014 Oct; 5(19):9079-91. PubMed ID: 25193864
[TBL] [Abstract][Full Text] [Related]
8. Prolactin Signaling Stimulates Invasion via Na(+)/H(+) Exchanger NHE1 in T47D Human Breast Cancer Cells.
Pedraz-Cuesta E; Fredsted J; Jensen HH; Bornebusch A; Nejsum LN; Kragelund BB; Pedersen SF
Mol Endocrinol; 2016 Jul; 30(7):693-708. PubMed ID: 27176613
[TBL] [Abstract][Full Text] [Related]
9. Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice.
Dandawate P; Kaushik G; Ghosh C; Standing D; Ali Sayed AA; Choudhury S; Subramaniam D; Manzardo A; Banerjee T; Santra S; Ramamoorthy P; Butler M; Padhye SB; Baranda J; Kasi A; Sun W; Tawfik O; Coppola D; Malafa M; Umar S; Soares MJ; Saha S; Weir SJ; Dhar A; Jensen RA; Thomas SM; Anant S
Gastroenterology; 2020 Apr; 158(5):1433-1449.e27. PubMed ID: 31786131
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone and prolactin receptors in adipogenesis: STAT-5 activation, suppressors of cytokine signaling, and regulation of insulin-like growth factor I.
Fleenor D; Arumugam R; Freemark M
Horm Res; 2006; 66(3):101-10. PubMed ID: 16735796
[TBL] [Abstract][Full Text] [Related]
11. A conformationally sensitive GHR [growth hormone (GH) receptor] antibody: impact on GH signaling and GHR proteolysis.
Jiang J; Wang X; He K; Li X; Chen C; Sayeski PP; Waters MJ; Frank SJ
Mol Endocrinol; 2004 Dec; 18(12):2981-96. PubMed ID: 15345746
[TBL] [Abstract][Full Text] [Related]
12. The role of prolactin and growth hormone in breast cancer.
Wennbo H; Törnell J
Oncogene; 2000 Feb; 19(8):1072-6. PubMed ID: 10713692
[TBL] [Abstract][Full Text] [Related]
13. Two wrongs can make a right: dimers of prolactin and growth hormone receptor antagonists behave as agonists.
Langenheim JF; Tan D; Walker AM; Chen WY
Mol Endocrinol; 2006 Mar; 20(3):661-74. PubMed ID: 16269515
[TBL] [Abstract][Full Text] [Related]
14. Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects.
Gallego MI; Binart N; Robinson GW; Okagaki R; Coschigano KT; Perry J; Kopchick JJ; Oka T; Kelly PA; Hennighausen L
Dev Biol; 2001 Jan; 229(1):163-75. PubMed ID: 11133161
[TBL] [Abstract][Full Text] [Related]
15. Human metastatic melanoma cell lines express high levels of growth hormone receptor and respond to GH treatment.
Sustarsic EG; Junnila RK; Kopchick JJ
Biochem Biophys Res Commun; 2013 Nov; 441(1):144-50. PubMed ID: 24134847
[TBL] [Abstract][Full Text] [Related]
16. Alpha
Castillo LF; Rivero EM; Goffin V; Lüthy IA
Cell Signal; 2017 Jun; 34():76-85. PubMed ID: 28302567
[TBL] [Abstract][Full Text] [Related]
17. Additive effects of a prolactin receptor antagonist, G129R, and herceptin on inhibition of HER2-overexpressing breast cancer cells.
Scotti ML; Langenheim JF; Tomblyn S; Springs AE; Chen WY
Breast Cancer Res Treat; 2008 Sep; 111(2):241-50. PubMed ID: 17955362
[TBL] [Abstract][Full Text] [Related]
18. Activation of growth hormone receptors by growth hormone and growth hormone antagonist dimers: insights into receptor triggering.
Yang N; Langenheim JF; Wang X; Jiang J; Chen WY; Frank SJ
Mol Endocrinol; 2008 Apr; 22(4):978-88. PubMed ID: 18096690
[TBL] [Abstract][Full Text] [Related]
19. Dynamic responses of prolactin, growth hormone and their receptors to hyposmotic acclimation in the olive flounder Paralichthys olivaceus.
Yuan M; Jia Q; Wang T; Lu Q; Tang L; Wang Y; Lu W
Gen Comp Endocrinol; 2017 Dec; 254():8-13. PubMed ID: 28927875
[TBL] [Abstract][Full Text] [Related]
20. Human GH receptor-IGF-1 receptor interaction: implications for GH signaling.
Gan Y; Buckels A; Liu Y; Zhang Y; Paterson AJ; Jiang J; Zinn KR; Frank SJ
Mol Endocrinol; 2014 Nov; 28(11):1841-54. PubMed ID: 25211187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
